Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $540,498 - $672,014
700 Added 4.22%
17,300 $15.3 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $13.2 Million - $16.5 Million
-18,200 Reduced 52.3%
16,600 $15 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $13.7 Million - $18.3 Million
23,100 Added 197.44%
34,800 $27.1 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $5.04 Million - $5.94 Million
-9,600 Reduced 45.07%
11,700 $6.82 Million
Q3 2023

Nov 15, 2023

BUY
$434.7 - $599.3 $8.56 Million - $11.8 Million
19,700 Added 1231.25%
21,300 $11.4 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $350,740 - $468,980
-1,000 Reduced 38.46%
1,600 $750,000
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $807,638 - $948,532
2,600 New
2,600 $893,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $266,832 - $304,083
900 New
900 $291,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.